Paid Clinical Trials in Bellevue, WA
As of June 2026, 109 paid clinical trials are recruiting in Bellevue, Washington. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Bellevue offers studies at sites including Northwest Clinical Research Center for conditions such as Schizophrenia, Crohn's Disease, Major Depressive Disorder, Obesity. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Bellevue
Trials by drug in Bellevue
Filter results
109 clinical trials
↓ Download CSVA Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
A Study of Brenipatide in Adult Participants With Schizophrenia
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Randomized Withdrawal Study in Patients With Schizophrenia
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
FORWARD CAD IDE Study
About research studies in Bellevue
Bellevue has approximately 109 recruiting research studies across a wide range of therapeutic areas. Washington hosts Fred Hutchinson Cancer Center, UW Medicine, and Seattle Children's — widely recognized for leadership in bone marrow transplantation, immunotherapy, and infectious disease research.
Top Research Study Locations in Bellevue
Researchers run research studies in Bellevue, WA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Northwest Clinical Research Center | Obesity, Osteoarthritis, Knee, Alzheimer Disease | 26 |
| Overlake Medical Center | Recurrent B Acute Lymphoblastic Leukemia, Stage IV Renal Cell Cancer AJCC v8, Advanced Esophageal Adenocarcinoma | 23 |
| FHCC Overlake | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 11 |
| Kaiser Permanente Bellevue Medical Center | Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, Colorectal Carcinoma | 3 |
| Pacific Northwest Retina | Age - Related Macular Degeneration (AMD), Age-Related Macular Degeneration, Choroidal Neovascularization | 3 |
| Washington Gastroenterology - Bellevue | Metabolic Dysfunction-Associated Steatotic Liver Disease, Ulcerative Colitis, Crohn's Disease | 3 |
| Lake Washington Vascular | Chronic Pelvic Pain Syndrome, Iliofemoral; Thrombosis, Pelvic Congestive Syndrome | 2 |
| Neurocrine Clinical Site | Schizophrenia | 2 |
| Pacific Northwest Retina (Bellevue) | Macular Edema Secondary to Inflammation | 2 |
| Seattle Neuropsychiatric Treatment Center | Depression, Major Depressive Disorder, Treatment Resistant Depression | 2 |
| Vanda Investigational Site | Major Depressive Disorder (MDD), Schizophrenia | 2 |
| Washington Gastroenterology- GIA | Crohn's Disease, Ulcerative Colitis | 2 |
| Anesis Pain- Bel-Red ASC | Lumbar Spinal Stenosis | 1 |
| Autobahn | Major Depressive Disorder | 1 |
| Bellevue Dermatology Clinic | Overweight or Obesity, Psoriasis | 1 |
| Bellevue Surgery Center | Lumbar Spinal Stenosis | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Dermatology of Seattle and Bellevue | Recurrent Squamous Cell Carcinoma | 1 |
| Draig Clinical Site | Major Depressive Disorder (MDD) | 1 |
| Factoria Eye Clinic | Myopia | 1 |
| GI Alliance | Crohn's Disease, Ulcerative Colitis | 1 |
| GI Alliance - Bellevue - Washington Gastroenterology | Crohn's Disease | 1 |
| Local Institution - 1253 | Alzheimer Disease | 1 |
| Mirador Therapeutics Selected Site | Crohn's Disease, Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC) | 1 |
| Northwest Clinical Research Center (NWCRC) | Diabetic Peripheral Neuropathic Pain | 1 |
Active & Upcoming Studies in Bellevue (2026)
Recruiting trials in Bellevue grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (29 active studies)
- A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer · Phase 3 · National Cancer Institute (NCI)
- Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response · Phase 3 · Canadian Cancer Trials Group
Neurology & pain (17 active studies)
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain · Phase 2 · Eli Lilly and Company
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain · Phase 2 · Eli Lilly and Company
Mental health & behavior (16 active studies)
- A Study of Brenipatide in Adult Participants With Schizophrenia · Phase 2 · Eli Lilly and Company
- A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder · Phase 2 · AbbVie
Eye & vision (6 active studies)
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) · Phase 2, Phase 3 · EyeBiotech Ltd.
- Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD · Phase 2 · ONL Therapeutics
Diabetes & metabolic (5 active studies)
- AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain · Phase 3 · Novo Nordisk A/S
- A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain · Phase 3 · Novo Nordisk A/S
Cardiovascular (2 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- FORWARD CAD IDE Study · Shockwave Medical, Inc.
Pediatric (1 active study)
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Common conditions studied in Bellevue
- Schizophrenia (6 active studies). Schizophrenia research tests muscarinic agonists, long-acting injectable antipsychotics, and cognitive remediation therapies.
- Crohn's Disease (5 active studies). Recruiting Crohn's Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Major Depressive Disorder (5 active studies). Major depressive disorder research examines rapid-acting agents, augmentation strategies, and digital therapeutics for treatment-resistant cases.
- Obesity (4 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Alzheimer Disease (3 active studies). Alzheimer's research investigates anti-amyloid antibodies, tau-targeted therapies, and lifestyle interventions aimed at slowing cognitive decline.
- Osteoarthritis, Knee (3 active studies). Recruiting Osteoarthritis, Knee studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Bellevue
- Eli Lilly and Company
- SWOG Cancer Research Network
- Intra-Cellular Therapies, Inc.
- National Cancer Institute (NCI)
- AbbVie
Local regulations and guidelines
Clinical trials in Washington are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Studies in Washington must also comply with the My Health My Data Act, which adds consumer-health-data protections on top of federal HIPAA requirements.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Bellevue. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Bellevue
Hipa.ai aggregates every recruiting study in Bellevue from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Bellevue?
There are approximately 109 recruiting clinical trials in Bellevue, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Bellevue pay participants?
Most recruiting trials in Bellevue compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Bellevue?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Bellevue?
The most common conditions under active study in Bellevue include Schizophrenia (6), Crohn's Disease (5), Major Depressive Disorder (5), Obesity (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Bellevue?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Bellevue on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Bellevue?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Bellevue?
Recruiting research sites in Bellevue include Northwest Clinical Research Center, Overlake Medical Center, FHCC Overlake, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Bellevue right now?
The largest active categories in Bellevue are Cancer & tumors (29), Neurology & pain (17), Mental health & behavior (16). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.